Literature DB >> 6123687

The case for global measles eradication.

D R Hopkins, A R Hinman, J P Koplan, J M Lane.   

Abstract

The global eradication of measles is desirable because the disease occurs almost universally, affects large numbers of children, can cause serious complications, and is responsible for about 900 000 deaths a year in developing countries. The feasibility of a measles eradication programme is suggested by the success of smallpox eradication, the availability of a heat-stable, cheap, and effective vaccine, and the fact that interruption of measles transmission has been achieved in some places. Eradication of measles globally would also result in the saving of the large sums of money being spent on measles treatment, vaccination, and surveillance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123687     DOI: 10.1016/s0140-6736(82)92510-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Evaluating the benefits of increasing measles immunization rates.

Authors:  J Zwanziger; P G Szilagyi; P Kaul
Journal:  Health Serv Res       Date:  2001-10       Impact factor: 3.402

2.  Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.

Authors:  G M Ginsberg; T H Tulchinsky
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

3.  Synthesizing epidemiological and economic optima for control of immunizing infections.

Authors:  Petra Klepac; Ramanan Laxminarayan; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 4.  Should measles be eradicated?

Authors:  F T Cutts; R Steinglass
Journal:  BMJ       Date:  1998-03-07

Review 5.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

6.  Immunisation practice and policy.

Authors:  D L Miller
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

7.  Costs of not eradicating measles.

Authors:  A R Hinman; K J Bart; D R Hopkins
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308

8.  Prevention: rhetoric and reality.

Authors:  L Eisenberg
Journal:  J R Soc Med       Date:  1984-04       Impact factor: 5.344

9.  Introduction of measles into a highly immunised West African community: the role of health care institutions.

Authors:  P Aaby; J Bukh; I M Lisse; A J Smits
Journal:  J Epidemiol Community Health       Date:  1985-06       Impact factor: 3.710

Review 10.  Quest for life-long protection by vaccination.

Authors:  W R Dowdle; W A Orenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.